trans-Fluorine Effect in Cyclopropane: Diastereoselective Synthesis of Fluorocyclopropyl Cabozantinib Analogs
Investigation of the trans-fluorine effect on the hydrolysis rate of diethyl 2-fluorocyclopropane-1,1-dicarboxylate provides synthetic access to both diastereomers of the fluorocyclopropyl analog of cabozantinib, a c-Met and VEGFR-2 inhibitor used as a first-line treatment for thyroid cancer and as...
Saved in:
| Published in: | ACS medicinal chemistry letters Vol. 11; no. 11; pp. 2146 - 2150 |
|---|---|
| Main Authors: | , , , , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
WASHINGTON
Amer Chemical Soc
12.11.2020
|
| Subjects: | |
| ISSN: | 1948-5875, 1948-5875 |
| Online Access: | Get more information |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Abstract | Investigation of the trans-fluorine effect on the hydrolysis rate of diethyl 2-fluorocyclopropane-1,1-dicarboxylate provides synthetic access to both diastereomers of the fluorocyclopropyl analog of cabozantinib, a c-Met and VEGFR-2 inhibitor used as a first-line treatment for thyroid cancer and as a second-line treatment for renal cell carcinoma. Despite some known potent examples, there are only a few drug molecules that contain fluorocyclopropane moieties. Herein, we present a case study in which the monofluoro analog of a known cyclopropane-containing drug molecule displays an improved in vitro profile compared to the parent nonfluorinated structure. The fluorocyclopropane moiety may offer valuable fine-tuning options for lead optimization in drug discovery. |
|---|---|
| AbstractList | Investigation of the trans-fluorine effect on the hydrolysis rate of diethyl 2-fluorocyclopropane-1,1-dicarboxylate provides synthetic access to both diastereomers of the fluorocyclopropyl analog of cabozantinib, a c-Met and VEGFR-2 inhibitor used as a first-line treatment for thyroid cancer and as a second-line treatment for renal cell carcinoma. Despite some known potent examples, there are only a few drug molecules that contain fluorocyclopropane moieties. Herein, we present a case study in which the monofluoro analog of a known cyclopropane-containing drug molecule displays an improved in vitro profile compared to the parent nonfluorinated structure. The fluorocyclopropane moiety may offer valuable fine-tuning options for lead optimization in drug discovery.Investigation of the trans-fluorine effect on the hydrolysis rate of diethyl 2-fluorocyclopropane-1,1-dicarboxylate provides synthetic access to both diastereomers of the fluorocyclopropyl analog of cabozantinib, a c-Met and VEGFR-2 inhibitor used as a first-line treatment for thyroid cancer and as a second-line treatment for renal cell carcinoma. Despite some known potent examples, there are only a few drug molecules that contain fluorocyclopropane moieties. Herein, we present a case study in which the monofluoro analog of a known cyclopropane-containing drug molecule displays an improved in vitro profile compared to the parent nonfluorinated structure. The fluorocyclopropane moiety may offer valuable fine-tuning options for lead optimization in drug discovery. Investigation of the trans-fluorine effect on the hydrolysis rate of diethyl 2-fluorocyclopropane-1,1-dicarboxylate provides synthetic access to both diastereomers of the fluorocyclopropyl analog of cabozantinib, a c-Met and VEGFR-2 inhibitor used as a first-line treatment for thyroid cancer and as a second-line treatment for renal cell carcinoma. Despite some known potent examples, there are only a few drug molecules that contain fluorocyclopropane moieties. Herein, we present a case study in which the monofluoro analog of a known cyclopropane-containing drug molecule displays an improved in vitro profile compared to the parent nonfluorinated structure. The fluorocyclopropane moiety may offer valuable fine-tuning options for lead optimization in drug discovery. |
| Author | Kinens, Artis Bobrovs, Raitis Veliks, Janis Videja, Melita Priede, Martins Kuka, Janis |
| Author_xml | – sequence: 1 givenname: Janis orcidid: 0000-0003-0955-8257 surname: Veliks fullname: Veliks, Janis organization: Latvian Inst Organ Synth, LV-1006 Riga, Latvia – sequence: 2 givenname: Melita surname: Videja fullname: Videja, Melita organization: Latvian Inst Organ Synth, LV-1006 Riga, Latvia – sequence: 3 givenname: Artis orcidid: 0000-0003-1992-525X surname: Kinens fullname: Kinens, Artis organization: Latvian Inst Organ Synth, LV-1006 Riga, Latvia – sequence: 4 givenname: Raitis orcidid: 0000-0002-0221-8658 surname: Bobrovs fullname: Bobrovs, Raitis organization: Latvian Inst Organ Synth, LV-1006 Riga, Latvia – sequence: 5 givenname: Martins orcidid: 0000-0002-9655-8345 surname: Priede fullname: Priede, Martins organization: Latvian Inst Organ Synth, LV-1006 Riga, Latvia – sequence: 6 givenname: Janis orcidid: 0000-0003-0955-8257 surname: Kuka fullname: Kuka, Janis email: janis.veliks@osi.lv organization: Latvian Inst Organ Synth, LV-1006 Riga, Latvia |
| BookMark | eNqNkM1LAzEQxYNUrFb_BclRkNVJ9ivxJmv9AMGDei5JdtZGskndpEr9612sgkdP82De7zFvDsjEB4-EHDM4Y8DZuTKxx9YssXeY0hkYAM5hh-wzWYisFHU5-aOn5CDGV4BK1jXskWmec1YIzvdJnwblY3bt1mGwHum869Akaj1tNsaF1RBWyuMFvbIqJhwwRHSjwb4jfdz4tMRoIw0d_Q4I5pfZONooHT6VT9ZbTS-9cuElHpLdTrmIRz9zRp6v50_NbXb_cHPXXN5nqgRImTYceM2wZLoyWqi8yjWDStS8YK2smOjytq2kVNJwOW5bXXd5IUSnmB45wWfkZJs73vK2xpgWvY0GnRu7hHVc8KLKQcpyfOWMiK31A3XoorHoDS5Wg-3VsFkAQCl5XRRiVIw1Nqlkg2_C2qcRPf0_yr8AZi6G3w |
| CitedBy_id | crossref_primary_10_3390_molecules28155785 crossref_primary_10_1002_chem_202301851 |
| Cites_doi | 10.1158/0008-5472.CAN-08-4889 10.1002/ejoc.201701030 10.1016/j.ejmech.2015.12.016 10.1039/c9cp05009d 10.1002/chem.201900349 10.1039/b610213c 10.1002/chem.201901840 10.1016/j.bmc.2005.01.043 10.1016/j.bioorg.2019.04.010 10.1021/acsmedchemlett.9b00035 10.1021/acscatal.9b00354 10.1016/j.cclet.2020.03.050 10.1039/c9ob02712b 10.1158/1535-7163.MCT-11-0264 10.1021/ja402393w 10.1021/cr4002879 10.1039/c6cs00351f 10.1002/chem.201202831 10.1055/s-0035-1560557 10.1021/acs.orglett.9b02867 10.1021/acs.jmedchem.7b01788 10.1002/ijch.201600038 10.1016/j.jhep.2004.04.013 10.1634/theoncologist.2017-0335 10.1021/acs.jmedchem.6b00472 10.1021/jm201330u 10.15586/jkcvhl.2018.109 |
| ContentType | Journal Article |
| DBID | 17B 1KM AOWDO BLEPL DTL EGQ 7X8 |
| DOI | 10.1021/acsmedchemlett.0c00220 |
| DatabaseName | Web of Knowledge Index Chemicus Web of Science - Science Citation Index Expanded - 2020 Web of Science Core Collection Science Citation Index Expanded Web of Science Primary (SCIE, SSCI & AHCI) MEDLINE - Academic |
| DatabaseTitle | Web of Science MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic Web of Science |
| Database_xml | – sequence: 1 dbid: 1KM name: Index Chemicus url: https://www.webofscience.com/wos/woscc/search-with-editions?editions=WOS.IC sourceTypes: Enrichment Source Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | no_fulltext_linktorsrc |
| Discipline | Pharmacy, Therapeutics, & Pharmacology |
| EISSN | 1948-5875 |
| EndPage | 2150 |
| ExternalDocumentID | 000592744800011 |
| GrantInformation_xml | – fundername: ERDF project grantid: 1.1.1.5/17/A/003 |
| GroupedDBID | --- 17B 1KM 53G 55A 5VS 7~N AABXI ABBLG ABJNI ABLBI ABMVS ABQRX ABUCX ACGFO ACGFS ACS ADBBV ADHLV AEESW AENEX AFEFF AHGAQ ALMA_UNASSIGNED_HOLDINGS AOIJS AQSVZ BAANH BAWUL BLEPL CUPRZ DIK DTL EBS ED~ F5P GGK GNL GROUPED_WOS_WEB_OF_SCIENCE GX1 HYE IH9 JG~ OK1 P2P RNS ROL RPM UI2 VF5 VG9 W1F XKZ 7X8 |
| ID | FETCH-LOGICAL-a500t-bc20271e51b6cb8a363b10687241d9618f3dd699a9c29a36db7f3488fa1b27182 |
| IEDL.DBID | 7X8 |
| ISICitedReferencesCount | 7 |
| ISICitedReferencesURI | https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestApp=WOS&DestLinkType=CitingArticles&UT=000592744800011 |
| ISSN | 1948-5875 |
| IngestDate | Thu Oct 02 10:57:57 EDT 2025 Fri Dec 05 22:47:27 EST 2025 Tue Sep 09 07:33:25 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 11 |
| Keywords | c-Met kinase inhibitors fluorocyclopropane VEGFR-2 kinase inhibitors anticancer cabozantinib |
| Language | English |
| LinkModel | DirectLink |
| LogoURL | https://exlibris-pub.s3.amazonaws.com/fromwos-v2.jpg |
| MergedId | FETCHMERGED-LOGICAL-a500t-bc20271e51b6cb8a363b10687241d9618f3dd699a9c29a36db7f3488fa1b27182 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| ORCID | 0000-0002-9655-8345 0000-0003-0955-8257 0000-0003-1992-525X 0000-0002-0221-8658 |
| OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/7667865 |
| PMID | 33214822 |
| PQID | 2463099510 |
| PQPubID | 23479 |
| PageCount | 5 |
| ParticipantIDs | webofscience_primary_000592744800011CitationCount proquest_miscellaneous_2463099510 webofscience_primary_000592744800011 |
| PublicationCentury | 2000 |
| PublicationDate | 2020-11-12 |
| PublicationDateYYYYMMDD | 2020-11-12 |
| PublicationDate_xml | – month: 11 year: 2020 text: 2020-11-12 day: 12 |
| PublicationDecade | 2020 |
| PublicationPlace | WASHINGTON |
| PublicationPlace_xml | – name: WASHINGTON |
| PublicationTitle | ACS medicinal chemistry letters |
| PublicationTitleAbbrev | ACS MED CHEM LETT |
| PublicationYear | 2020 |
| Publisher | Amer Chemical Soc |
| Publisher_xml | – name: Amer Chemical Soc |
| References | Wei, DS (WOS:000475378400011) 2019; 88 Talele, TT (WOS:000385607100004) 2016; 59 Veliks, J (WOS:000461713000013) 2019; 25 (000592744800011.20) 1000 Chawner, SJ (WOS:000410792200004) 2017; 2017 Thiehoff, C (WOS:000394572500011) 2017; 57 Beaulieu, LPB (WOS:000319856700008) 2013; 135 Norman, MH (WOS:000301170000007) 2012; 55 Schmidinger, M (WOS:000427020800007) 2018; 23 Mei, HB (WOS:000476851600001) 2019; 25 Jiang, BA (WOS:000181302800040) 2003 KIMURA, Y (WOS:A1994PJ90900019) 1994; 37 Liu, CJ (WOS:000461537500028) 2019; 10 Kazia, AK (WOS:000517113000009) 2020; 18 Díaz, N (WOS:000506841300038) 2019; 21 Prakash, GKS (WOS:000252989500009) 2008; 10 Ye, S (WOS:000227891000015) 2005; 13 Zhang, J (WOS:000369191800044) 2016; 108 Wang, SY (WOS:000223455500012) 2004; 41 Ni, CF (WOS:000385181300001) 2016; 45 Mei, HB (WOS:000582384200040) 2020; 31 David, E (WOS:000311111900002) 2012; 18 Yakes, FM (WOS:000298344400009) 2011; 10 Purser, S (WOS:000252411800007) 2008; 37 Wang, J (WOS:000332144700009) 2014; 114 Melngaile, R (WOS:000485089300118) 2019; 21 Pons, A (WOS:000460600600091) 2019; 9 Pons, A (WOS:000389329500009) 2016; 48 Meanwell, NA (WOS:000440521300004) 2018; 61 Del Vecchio, SJ (WOS:000452488400001) 2018; 5 Qian, F (WOS:000270935500016) 2009; 69 BURGESS, K (WOS:A1995QU49100006) 1995; 36 |
| References_xml | – volume: 69 start-page: 8009 year: 2009 ident: WOS:000270935500016 article-title: Inhibition of Tumor Cell Growth, Invasion, and Metastasis by EXEL-2880 (XL880, GSK1363089), a Novel Inhibitor of HGF and VEGF Receptor Tyrosine Kinases publication-title: CANCER RESEARCH doi: 10.1158/0008-5472.CAN-08-4889 – volume: 2017 start-page: 5015 year: 2017 ident: WOS:000410792200004 article-title: Divergent Synthesis of Cyclopropane-Containing Lead-Like Compounds, Fragments and Building Blocks through a Cobalt Catalyzed Cyclopropanation of Phenyl Vinyl Sulfide publication-title: EUROPEAN JOURNAL OF ORGANIC CHEMISTRY doi: 10.1002/ejoc.201701030 – volume: 108 start-page: 495 year: 2016 ident: WOS:000369191800044 article-title: Recent advances in the development of dual VEGFR and c-Met small molecule inhibitors as anticancer drugs publication-title: EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY doi: 10.1016/j.ejmech.2015.12.016 – volume: 21 start-page: 25258 year: 2019 ident: WOS:000506841300038 article-title: Fluorine conformational effects characterized by energy decomposition analysis publication-title: PHYSICAL CHEMISTRY CHEMICAL PHYSICS doi: 10.1039/c9cp05009d – year: 1000 ident: 000592744800011.20 article-title: C-met Modulators and Methods of Use – volume: 25 start-page: 3786 year: 2019 ident: WOS:000461713000013 article-title: Fluoromethylene Transfer from Diarylfluoromethylsulfonium Salts: Synthesis of Fluorinated Epoxides publication-title: CHEMISTRY-A EUROPEAN JOURNAL doi: 10.1002/chem.201900349 – volume: 37 start-page: 320 year: 2008 ident: WOS:000252411800007 article-title: Fluorine in medicinal chemistry publication-title: CHEMICAL SOCIETY REVIEWS doi: 10.1039/b610213c – volume: 25 start-page: 11797 year: 2019 ident: WOS:000476851600001 article-title: Fluorine-Containing Drugs Approved by the FDA in 2018 publication-title: CHEMISTRY-A EUROPEAN JOURNAL doi: 10.1002/chem.201901840 – volume: 13 start-page: 2489 year: 2005 ident: WOS:000227891000015 article-title: Fluorinated phenylcyclopropylamines. Part 4: Effects of aryl substituents and stereochemistry on the inhibition of monoamine oxidases by 1-aryl-2-fluoro-cyclopropylamines publication-title: BIOORGANIC & MEDICINAL CHEMISTRY doi: 10.1016/j.bmc.2005.01.043 – volume: 88 start-page: ARTN 102916 year: 2019 ident: WOS:000475378400011 article-title: Synthesis and anti-tumor activity of [1,4] dioxino [2,3-f] quinazoline derivatives as dual inhibitors of c-Met and VEGFR-2 publication-title: BIOORGANIC CHEMISTRY doi: 10.1016/j.bioorg.2019.04.010 – volume: 10 start-page: 383 year: 2019 ident: WOS:000461537500028 article-title: Identification of Imidazo[1,2-b]pyridazine Derivatives as Potent, Selective, and Orally Active Tyk2 JH2 Inhibitors publication-title: ACS MEDICINAL CHEMISTRY LETTERS doi: 10.1021/acsmedchemlett.9b00035 – volume: 9 start-page: 2594 year: 2019 ident: WOS:000460600600091 article-title: Catalytic Enantioselective Cyclopropanation of α-Fluoroacrylates: An Experimental and Theoretical Study publication-title: ACS CATALYSIS doi: 10.1021/acscatal.9b00354 – volume: 31 start-page: 2401 year: 2020 ident: WOS:000582384200040 article-title: Fluorine-containing drugs approved by the FDA in 2019 publication-title: CHINESE CHEMICAL LETTERS doi: 10.1016/j.cclet.2020.03.050 – volume: 18 start-page: 1384 year: 2020 ident: WOS:000517113000009 article-title: Johnson-Corey-Chaykovsky fluorocyclopropanation of double activated alkenes: scope and limitations publication-title: ORGANIC & BIOMOLECULAR CHEMISTRY doi: 10.1039/c9ob02712b – volume: 10 start-page: 2298 year: 2011 ident: WOS:000298344400009 article-title: Cabozantinib (XL184), a Novel MET and VEGFR2 Inhibitor, Simultaneously Suppresses Metastasis, Angiogenesis, and Tumor Growth publication-title: MOLECULAR CANCER THERAPEUTICS doi: 10.1158/1535-7163.MCT-11-0264 – volume: 135 start-page: 7819 year: 2013 ident: WOS:000319856700008 article-title: Highly Enantioselective Simmons-Smith Fluorocyclopropanation of Allylic Alcohols via the Halogen Scrambling Strategy of Zinc Carbenoids publication-title: JOURNAL OF THE AMERICAN CHEMICAL SOCIETY doi: 10.1021/ja402393w – volume: 114 start-page: 2432 year: 2014 ident: WOS:000332144700009 article-title: Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001-2011) publication-title: CHEMICAL REVIEWS doi: 10.1021/cr4002879 – volume: 37 start-page: 3344 year: 1994 ident: WOS:A1994PJ90900019 article-title: (FLUOROCYCLOPROPYL)QUINOLONES .2. SYNTHESIS AND STEREOCHEMICAL STRUCTURE-ACTIVITY-RELATIONSHIPS OF CHIRAL 7-(7-AMINO-5-AZASPIRO[2.4]HEPTAN-5-YL)-1-(2-FLUOROCYCLOPROPYL)QUINOLONE ANTIBACTERIAL AGENTS publication-title: JOURNAL OF MEDICINAL CHEMISTRY – volume: 45 start-page: 5441 year: 2016 ident: WOS:000385181300001 article-title: The unique fluorine effects in organic reactions: recent facts and insights into fluoroalkylations publication-title: CHEMICAL SOCIETY REVIEWS doi: 10.1039/c6cs00351f – volume: 18 start-page: 14904 year: 2012 ident: WOS:000311111900002 article-title: Syntheses and Applications of Monofluorinated Cyclopropanes publication-title: CHEMISTRY-A EUROPEAN JOURNAL doi: 10.1002/chem.201202831 – volume: 48 start-page: 4060 year: 2016 ident: WOS:000389329500009 article-title: Synthesis and Applications of Fluorocyclopropanes publication-title: SYNTHESIS-STUTTGART doi: 10.1055/s-0035-1560557 – volume: 21 start-page: 7174 year: 2019 ident: WOS:000485089300118 article-title: Diastereoselective Monofluorocyclopropanation Using Fluoromethylsulfonium Salts publication-title: ORGANIC LETTERS doi: 10.1021/acs.orglett.9b02867 – start-page: 536 year: 2003 ident: WOS:000181302800040 article-title: A convenient stereoselective synthesis of trifluoromethyl-substituted polyfunctionalized cyclopropane:: synthesis of (±)-trans-trifluoronorcoronamic acid publication-title: CHEMICAL COMMUNICATIONS – volume: 61 start-page: 5822 year: 2018 ident: WOS:000440521300004 article-title: Fluorine and Fluorinated Motifs in the Design and Application of Bioisosteres for Drug Design publication-title: JOURNAL OF MEDICINAL CHEMISTRY doi: 10.1021/acs.jmedchem.7b01788 – volume: 57 start-page: 92 year: 2017 ident: WOS:000394572500011 article-title: The Fluorine Gauche Effect: A Brief History publication-title: ISRAEL JOURNAL OF CHEMISTRY doi: 10.1002/ijch.201600038 – volume: 41 start-page: 267 year: 2004 ident: WOS:000223455500012 article-title: SU5416 is a potent inhibitor of hepatocyte growth factor receptor (c-Met) and blocks HGF-induced invasiveness of human HepG2 hepatoma cells publication-title: JOURNAL OF HEPATOLOGY doi: 10.1016/j.jhep.2004.04.013 – volume: 23 start-page: 306 year: 2018 ident: WOS:000427020800007 article-title: Management of Adverse Events Associated with Cabozantinib Therapy in Renal Cell Carcinoma publication-title: ONCOLOGIST doi: 10.1634/theoncologist.2017-0335 – volume: 59 start-page: 8712 year: 2016 ident: WOS:000385607100004 article-title: The "Cyclopropyl Fragment" is a Versatile Player that Frequently Appears in Preclinical/Clinical Drug Molecules publication-title: JOURNAL OF MEDICINAL CHEMISTRY doi: 10.1021/acs.jmedchem.6b00472 – volume: 55 start-page: 1858 year: 2012 ident: WOS:000301170000007 article-title: Structure-Based Design of Novel Class II c-Met Inhibitors: 1. Identification of Pyrazolone-Based Derivatives publication-title: JOURNAL OF MEDICINAL CHEMISTRY doi: 10.1021/jm201330u – volume: 10 start-page: 557 year: 2008 ident: WOS:000252989500009 article-title: Direct electrophilic monofluoromethylation publication-title: ORGANIC LETTERS – volume: 5 start-page: 1 year: 2018 ident: WOS:000452488400001 article-title: Cabozantinib for the Management of Metastatic Clear Cell Renal Cell Carcinoma publication-title: JOURNAL OF KIDNEY CANCER AND VHL doi: 10.15586/jkcvhl.2018.109 – volume: 36 start-page: 2725 year: 1995 ident: WOS:A1995QU49100006 article-title: PRACTICAL ASYMMETRIC SYNTHESES OF ALL 4 2,3-METHANOLEUCINE STEREOISOMERS publication-title: TETRAHEDRON LETTERS |
| SSID | ssj0069770 |
| Score | 2.2683647 |
| Snippet | Investigation of the trans-fluorine effect on the hydrolysis rate of diethyl 2-fluorocyclopropane-1,1-dicarboxylate provides synthetic access to both... |
| Source | Web of Science |
| SourceID | proquest webofscience |
| SourceType | Aggregation Database Enrichment Source Index Database |
| StartPage | 2146 |
| SubjectTerms | Chemistry, Medicinal Life Sciences & Biomedicine Pharmacology & Pharmacy Science & Technology |
| Title | trans-Fluorine Effect in Cyclopropane: Diastereoselective Synthesis of Fluorocyclopropyl Cabozantinib Analogs |
| URI | http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestApp=WOS&DestLinkType=FullRecord&UT=000592744800011 https://www.proquest.com/docview/2463099510 |
| Volume | 11 |
| WOS | 000592744800011 |
| WOSCitedRecordID | wos000592744800011 |
| hasFullText | |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1NT9wwELWgcODSlgLqAkVGWnHCkE8n5oKqLSsk1NVKpdLeVvEXRFoSWgek8OuZ8WbZIvWAxDWJE9sZzTzbM-8R0i-yQFtrOEuiwLIk1SnLbaKZCBTgcyF5aqQXm8hGo3wyEeNuw811aZULn-gdta4V7pGfRgmPAc2ACZ3f_2GoGoWnq52ExipZiwHKYEpXNnk5ReCAbXxBpEiwuihLFxXCUXhaKIcJkLfmDqanOQkUBrPgFcz8TyDyQWf46b3d_Uw-dnCTfp_bxyZZMdUXcjSe81W3x_R6WX7ljukRHS-ZrNstctdgJGPD2QOm6Rk6pzqmZUUHrZrV0CXwJeaM_igL5FswtfOqOuBA6a-2AmjpSkdrS_0LarVo087oAGzvqUCVilJSJEapb9w2-T28uB5csk6fgaGMQsOkwp2T0KSh5ErmRcxjCSvMPANUoFFJxsZacyEKoSIBd7XMbAwOwxahhHZ5tEM-VHVlvhLKkzS0cA3WyyqRJgGvy2UkQqELlELLe-RwMc1TsH881IDx1Q9uupzoHun_-8em93O6jqnnoEEixNwD4B4J3_LYoKNIR2qAZvcNn98jGxGuxTFFMNonaxbch_lG1tVjU7q_BwDdr34eePt8BlqD8T0 |
| linkProvider | ProQuest |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=trans-Fluorine+Effect+in+Cyclopropane%3A+Diastereoselective+Synthesis+of+Fluorocyclopropyl+Cabozantinib+Analogs&rft.jtitle=ACS+medicinal+chemistry+letters&rft.au=Veliks%2C+Janis&rft.au=Videja%2C+Melita&rft.au=Kinens%2C+Artis&rft.au=Bobrovs%2C+Raitis&rft.date=2020-11-12&rft.pub=Amer+Chemical+Soc&rft.issn=1948-5875&rft.eissn=1948-5875&rft.volume=11&rft.issue=11&rft.spage=2146&rft.epage=2150&rft_id=info:doi/10.1021%2Facsmedchemlett.0c00220&rft_id=info%3Apmid%2F33214822&rft_id=info%3Apmid%2F33214822&rft.externalDBID=n%2Fa&rft.externalDocID=000592744800011 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1948-5875&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1948-5875&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1948-5875&client=summon |